Nov. 19 at 5:45 PM
Big moment coming for
$BCTX at SABCS 2025 🔥
BriaCell is rolling out three clinical and one preclinical posters, including two late-breaking clinical presentations — a clear signal they’re bringing meaningful data to one of the biggest breast cancer stages of the year.
These posters hit on everything from Phase 3 genotype matching & biomarkers to survival results from their Phase II Bria-IMT allogenic vaccine, with all presentations set for December 10. Serious visibility boost for the company.
See the complete stock outlook here👉
https://www.zacks.com/stock/quote/BCTX?cid=sm-stocktwits-0-quote_overview-oc-21732&ADID=SYND_STOCKTWITS_TWEET_0_QUOTEOVERVIEW_OC_21732